Early detection of a two-long-terminal-repeat junction molecule in the cytoplasm of recombinant murine leukemia virus-infected cells

Journal of Virology

Volumn 78, Issue 12, 2004, Pages 6190-6199

  Serhan, Fatima ^a   Penaud, Magalie ^a   Petit, Caroline ^b   Leste Lasserre, Thierry ^b   Trajcevski, Stéphane ^c   Klatzmann, David ^c   Duisit, Ghislaine ^a   Sonigo, Pierre ^b   Moullier, Philippe ^a,d  

^a INSERM   (France)

^b INSTITUT COCHIN   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APHIDICOLIN; DEOXYRIBONUCLEASE; RNA DIRECTED DNA POLYMERASE; VIRUS DNA; ZIDOVUDINE;

ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CELL NUCLEUS TRANSPLANTATION; CONTROLLED STUDY; CYTOPLASM; DNA DETERMINATION; DNA SYNTHESIS; HUMAN; HUMAN CELL; INFECTION COMPLICATION; LONG TERMINAL REPEAT; LONG TERMINAL REPEAT JUNCTION SEQUENCE; MURINE LEUKEMIA VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUPERNATANT;

ANIMALS; APHIDICOLIN; BASE SEQUENCE; CELL LINE; CYTOPLASM; DNA, VIRAL; ENZYME INHIBITORS; GENETIC VECTORS; HUMANS; LEUKEMIA VIRUS, MURINE; MICE; MITOSIS; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; RECOMBINATION, GENETIC; TERMINAL REPEAT SEQUENCES; VIRUS REPLICATION;

EID: 2642583928     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.12.6190-6199.2004     Document Type: Article

References (53)

1. Bouyac-Bertoia, M., J. D. Dvorin, R. A. Fouchier, Y. Jenkins, B. E. Meyer, L. I. Wu, M. Emerman, and M. H. Malim. 2001. HIV-1 infection requires a functional integrase NLS. Mol. Cell 7:1025-1035.
2. Bowerman, B., P. O. Brown, J. M. Bishop, and H. E. Varmus. 1989. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 3:469-478.
3. Brown, P. 1990. Integration of retroviral DNA. Curr. Top. Microbiol. Immunol. 157:19-48.
4. Brown, P. O., B. Bowerman, H. E. Varmus, and J. M. Bishop. 1987. Correct integration of retroviral DNA in vitro. Cell 49:347-356.
5. Brown, P. O., B. Bowerman, H. E. Varmus, and J. M. Bishop. 1989. Retroviral integration: structure of the initial covalent product and its precursor, and a role for the viral IN protein. Proc. Natl. Acad. Sci. USA 86:2525-2529.
6. Bukrinsky, M., N. Sharova, M. Dempsey, T. Stanwick, A. Bukrinskaya, S. Haggerty, and M. Stevenson. 1992. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl. Acad. Sci. USA 89:6580-6584.
7. Bukrinsky, M., N. Sharova, and M. Stevenson. 1993. Human immunodeficiency virus type 1 2-LTR circles reside in a nucleoprotein complex which is different from the preintegration complex. J. Virol. 67:6863-6865.
8. Butler, S. L., E. P. Johnson, and F. D. Bushman. 2002. Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles. J. Virol. 76:3739-3747.
9. Colicelli, J., and S. P. Goff. 1986. Structure of a cloned circular retroviral DNA containing a tRNA sequence between the terminal repeats. J. Virol. 57:674-677.
10. Cosset, F. L., Y. Takeuchi, J. L. Battini, R. A. Weiss, and M. K. L. Collins. 1995. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69:7430-7436.
11. Delelis, O., A. Saïb, and P. Sonigo. 2003. Biphasic DNA synthesis in spumaviruses. J. Virol. 77:8141-8146.
12. Duisit, G., A. Salvetti, P. Moullier, and F. Cosset. 1999. Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines. Hum. Gene Ther. 10:189-200.
13. Dunn, K., A. Aotaki-Keen, F. Putkey, and L. Hjelmeland. 1996. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Exp. Eye Res. 62:155-169.
14. Dvorin, J., P. Bell, G. Maul, M. Yamashita, M. Emerman, and M. Malim. 2002. Reassessment of the roles of integrase and the central DNA flap in human immunodeficiency virus type 1 nuclear import. J. Virol. 2002:12087-12096.
15. Farnet, C. M., and W. A. Haseltine. 1991. Circularization of human immunodeficiency virus type 1 DNA in vitro. J. Virol. 65:6942-6952.
16. Farnet, C. M., and W. A. Haseltine. 1990. Integration of human immunodeficiency virus type 1 DNA in vitro. Proc. Natl. Acad. Sci. USA 87:4164-4168.
17. Fujiwara, T., H. Fujiwara, and H. Nakano. 1988. Retroviral DNA integration: structure of an integration intermediate. Cell 54:497-504.
18. Gallay, P., T. Hope, D. Chin, and D. Trono. 1997. HIV-1 infection of nondividing cells through the recognition of integrase by the importinjkaryopherin pathway. Proc. Natl. Acad. Sci. USA 94:9825-9830.
19. Guntaka, R. V., O. C. Richards, P. R. Shank, H. J. Kung, and N. Davidson. 1976. Covalently closed circular DNA of avian sarcoma virus: purification from nuclei of infected quail tumor cells and measurement by electron microscopy and gel electrophoresis. J. Mol. Biol. 106:337-357.
20. Hatziioannou, T., and S. P. Goff. 2001. Infection of nondividing cells by Rous sarcoma virus. J. Virol. 75:9526-9531.
21. Heinzinger, N., M. Bukinsky, S. Haggerty, A. Ragland, V. N. KewalRamani, M. Lee, H. Gendelman, M. Stevenson, and M. Emerman. 1994. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91:7311-7315.
22. Hong, T., K. Drlica, A. Pinter, and E. Murphy. 1991. Circular DNA of human immunodeficiency virus: analysis of circle junction nucleotide sequences. J. Virol. 65:551-555.
23. Hurford, R. K., Jr., G. Dranoff, R. C. Mulligan, and R. I. Tepper. 1995. Gene therapy of metastatic cancer by in vivo retroviral gene targeting. Nat. Genet. 10:430-435.
24. Jurriaans, S., A. de Ronde, J. Dekker, J. Goudsmit, and M. Cornelissen. 1992. Analysis of human immunodeficiency virus type 1 LTR-LTR junctions in peripheral blood mononuclear cells of infected individuals. J. Gen. Virol. 73:1537-1541.
25. Katz, R. A., J. G. Greger, K. Darby, P. Boimel, G. F. Rall, and A. M. Skalka. 2002. Transduction of interphase cells by avian sarcoma virus. J. Virol. 76:5422-5434.
26. Kim, S. S., X. J. You, M. E. Harmon, J. Overbaugh, and H. Fan. 2001. Use of helper-free replication-defective simian immunodeficiency virus-based vectors to study macrophage and T tropism: evidence for distinct levels of restriction in primary macrophages and a T-cell line. J. Virol. 75:2288-2300.
27. Lewis, P., M. Hensel, and M. Emerman. 1992. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 11:3053-3058.
28. Lewis, P. F., and M. Emerman. 1994. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68:510-516.
29. Limon, A., N. Nakajima, R. Lu, H. C. Ghory, and A. Engelman. 2002. Wild-type levels of nuclear localization and human immunodeficiency virus type 1 replication in the absence of the central DNA flap. J. Virol. 76:12078-12086.
30. Lobel, L., J. Murphy, and S. Goff. 1989. The palindromic LTR-LTR junction of Moloney murine leukemia virus is not an efficient substrate for proviral integration. J. Virol. 63:2629-2637.
31. Lori, F., A. Malykh, A. Cara, D. Sun, J. Weinstein, J. Lisziewicz, and R. Gallo. 1994. Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication. Science 266:801-805.
32. McKnight, A., D. J. Griffiths, M. Dittmar, P. Clapham, and E. Thomas. 2001. Characterization of a late entry event in the replication cycle of human immunodeficiency virus type 2. J. Virol. 75:6914-6922.
33. Miller, D. G., M. A. Adam, and A. D. Miller. 1990. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10:4239-4242.
34. Murphy, S. J., H. Chong, S. Bell, R. M. Diaz, and R. G. Vile. 2002. Novel integrating adenoviral/retroviral hybrid vector for gene therapy. Hum. Gene Ther. 13:745-760.
35. Pierson, T. C., T. L. Kieffer, C. T. Ruff, C. Buck, S. J. Gange, and R. F. Siliciano. 2002. Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication. J. Virol. 76:4138-4144.
36. Quan, Y., L. Rong, C. Liang, and M. A. Wainberg. 1999. Reverse transcriptase inhibitors can selectively block the synthesis of differently sized viral DNA transcripts in cells acutely infected with human immunodeficiency virus type 1. J. Virol. 73:6700-6707.
37. Reil, H., A. Bukovsky, H. Gelderblom, and H. Gottlinger. 1998. Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J. 17:2699-2708.
38. Roe, T. Y., T. C. Reynolds, G. Yu, and P. O. Brown. 1993. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12:2099-2108.
39. Schmidtmayerova, H., M. Alfano, G. Nuovo, and M. Bukrinsky. 1998. Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level. J. Virol. 72:4633-4642.
40. Serhan, F., N. Jourdan, S. Saleun, P. Moullier, and G. Duisit. 2002. Characterization of producer cell-dependent restriction of murine leukemia virus replication. J. Virol. 76:6609-6617.
41. Shank, P., S. Hughes, H. Kung, J. Majors, N. Quintrell, R. Guntaka, J. Bishop, and H. Varmus. 1978. Mapping unintegrated avian sarcoma virus DNA: termini of linear DNA bear 300 nucleotides present once or twice in two species of circular DNA. Cell 15:1383-1395.
42. Shank, P., and H. E. Varmus. 1978. Virus-specific DNA in the cytoplasm of avian sarcoma virus-infected cells is a precursor to covalently closed circular viral DNA in the nucleus. J. Virol. 25:104-114.
43. Shoemaker, C., S. Goff, E. Gilboa, M. Paskind, S. W. Mitra, and D. Baltimore. 1980. Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: implications for retrovirus integration. Proc. Natl. Acad. Sci. USA 77:3932-3936.
44. Pro mediated by M-MuLV and HIV-1 reverse transcriptases. Virology 229:437-446.
45. Solly, S., S. Trajcevski, C. Frisén, G. Holzer, E. Nelson, B. Clerc, E. Abordo-Adesida, M. G. Castro, P. R. Lowenstein, and D. Klatzmann. 2003. Replicative retroviral vectors for cancer gene therapy. Cancer Gene Ther. 10:30-39.
46. Teo, I. A., J. Morlese, J. W. Choi, and S. Shaunak. 2002. Reliable and reproducible LightCycler qPCR for HIV-1 DNA 2-LTR circles. J. Immunol. Methods 270:109-118.
47. Trono, D. 1992. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J. Virol. 66:4893-4900.
48. Wu, X., Y. Li, B. Crise, and S. Burgess. 2003. Transcription start regions in the human genome are favored targets for MLV integration. Science 300:1749-1751.
49. Yoshimura, F., and R. Weinberg. 1979. Restriction endonuclease cleavage of linear and closed circular murine leukemia viral DNAs: discovery of a smaller circular form. Cell 16:323-332.
50. Yuan, B., A. Fassati, A. Yuech, and S. Goff. 2002. Characterization of Moloney murine leukemia virus p12 mutants blocked during early events of infection. J. Virol. 76:10801-10810.
51. Yuan, B., X. Li, and S. P. Goff. 1999. Mutations altering the Moloney murine leukemia virus p12 gag protein affect virion production and early events of the virus life cycle. EMBO J. 18:4700-4710.
52. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
53. Zennou, V., C. Petit, D. Guetard, U. Nerhbass, L. Montagnier, and P. Charneau. 2000. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101:173-185.